Skip to main content
. 2016 Dec 7;123(6):1061–1070. doi: 10.1002/cncr.30437

Figure 3.

Figure 3

Patient risk and overall survival as assessed by Met IHC expression. (A) Cox proportional hazards model evaluation of IHC classification with respect to overall survival. HRs along with 95% CIs comparing Met‐positive and Met‐negative patients at each cutoff value are depicted. (B,C) Kaplan‐Meier curves depicting the overall survival of the subjects by the Met IHC status with cutoffs of (B) 25% and (C) 50%. (D) Cox proportional hazards model evaluation of the IHC status with respect to overall survival. A multivariate analysis was performed, and 25% staining was used as the Met‐positive cutoff. HRs along with 95% CIs for each baseline covariate are depicted. CI indicates confidence interval; EGJ, esophagogastric junction; HER2, human epidermal growth factor receptor 2; HR, hazard ratio; IHC, immunohistochemistry; SRM, selected reaction monitoring.